Hao Zhu

机构：Nanjing Agricultural University, University of Freiburg, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, China Tobacco, Nanjing Sport Institute, Southwestern Medical Center, Bernstein Center for Computational Neuroscience Freiburg, Shanghai Fudan Microelectronics (China), Southwestern Medical Center, Beihang University, The University of Texas Southwestern Medical Center · ORCID：0000-0002-8417-9698

发表论文 256 篇 · 总被引 10620 次 · h-index 50

代表论文

• The origin of hepatocellular carcinoma depends on metabolic zonation (2025 · Science · 被引 23)
• Spatial regulation of glucose and lipid metabolism by hepatic insulin signaling (2025 · Cell Metabolism · 被引 21)
• Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14 (2024 · Science Advances · 被引 15)
• Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma (2025 · JAMA Network Open · 被引 14)
• Dual TIGIT and PD-1 blockade with domvanalimab plus zimberelimab in hepatocellular carcinoma refractory to anti-PD-1 therapies: the phase 2 LIVERTI trial (2025 · Nature Communications · 被引 12)
• Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation (2025 · Journal of Hepatology · 被引 10)